These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084 [TBL] [Abstract][Full Text] [Related]
3. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico. Torres-Ibarra L; Cuzick J; Lorincz AT; Spiegelman D; Lazcano-Ponce E; Franco EL; Moscicki AB; Mahmud SM; Wheeler CM; Rivera-Paredez B; Hernández-López R; León-Maldonado L; Salmerón J; JAMA Netw Open; 2019 Nov; 2(11):e1915781. PubMed ID: 31747033 [TBL] [Abstract][Full Text] [Related]
4. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial. Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579 [TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of an artificial intelligence-assisted cytological system among screening strategies for a cervical cancer high-risk population. Yang W; Jin X; Huang L; Jiang S; Xu J; Fu Y; Song Y; Wang X; Wang X; Yang Z; Meng Y BMC Cancer; 2024 Jun; 24(1):776. PubMed ID: 38937664 [TBL] [Abstract][Full Text] [Related]
6. Defining Optimal Triage Strategies for hrHPV Screen-Positive Women-An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry. Stanczuk GA; Baxter GJ; Currie H; Forson W; Lawrence JR; Cuschieri K; Wilson A; Patterson L; Govan L; Black J; Palmer T; Arbyn M Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1629-1635. PubMed ID: 28887297 [No Abstract] [Full Text] [Related]
7. Clinical Performance of Triage Strategies for Hr-HPV-Positive Women; A Longitudinal Evaluation of Cytology, p16/K-67 Dual Stain Cytology, and HPV16/18 Genotyping. Stanczuk G; Currie H; Forson W; Baxter G; Lawrence J; Wilson A; Palmer T; Arbyn M; Cuschieri K Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1492-1498. PubMed ID: 35511738 [TBL] [Abstract][Full Text] [Related]
8. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening]. Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163 [TBL] [Abstract][Full Text] [Related]
9. Triage options to manage high-risk human papillomavirus-positive women: A population-based cross-sectional study from rural China. Rezhake R; Chen F; Hu SY; Zhao XL; Zhang X; Cao J; Qiao YL; Zhao FH; Arbyn M Int J Cancer; 2020 Oct; 147(8):2053-2064. PubMed ID: 32249409 [TBL] [Abstract][Full Text] [Related]
10. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16 Song F; Yan P; Huang X; Wang C; Qu X; Du H; Wu R BMC Infect Dis; 2021 Apr; 21(1):400. PubMed ID: 33931022 [TBL] [Abstract][Full Text] [Related]
11. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China. Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450 [TBL] [Abstract][Full Text] [Related]
12. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples. Song F; Du H; Wang C; Huang X; Wu R; PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936 [TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study. Gori S; Battagello J; Gustinucci D; Campari C; Zorzi M; Frayle H; Passamonti B; Sartori G; Bulletti S; Fodero C; Cesarini E; Faggiano R; Del Mistro A BJOG; 2021 Jul; 128(8):1353-1362. PubMed ID: 33326680 [TBL] [Abstract][Full Text] [Related]
14. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial. Wright TC; Behrens CM; Ranger-Moore J; Rehm S; Sharma A; Stoler MH; Ridder R Gynecol Oncol; 2017 Jan; 144(1):51-56. PubMed ID: 28094038 [TBL] [Abstract][Full Text] [Related]
15. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology. Agorastos T; Chatzistamatiou K; Katsamagkas T; Koliopoulos G; Daponte A; Constantinidis T; Constantinidis TC; PLoS One; 2015; 10(3):e0119755. PubMed ID: 25793281 [TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study. Bao H; Bi H; Zhang X; Zhao Y; Dong Y; Luo X; Zhou D; You Z; Wu Y; Liu Z; Zhang Y; Liu J; Fang L; Wang L Gynecol Oncol; 2020 Oct; 159(1):171-178. PubMed ID: 32814641 [TBL] [Abstract][Full Text] [Related]
17. Adjunctive testing by cytology, p16/Ki-67 dual-stained cytology or HPV16/18 E6 oncoprotein for the management of HPV16/18 screen-positive women. Torres-Ibarra L; Lorincz AT; Wheeler CM; Cuzick J; Hernández-López R; Spiegelman D; León-Maldonado L; Rivera-Paredez B; Méndez-Hernández P; Lazcano-Ponce E; Salmerón J Int J Cancer; 2021 May; 148(9):2264-2273. PubMed ID: 33252834 [TBL] [Abstract][Full Text] [Related]
18. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening. Tay SK; Lin LE; Goh RC Ann Acad Med Singap; 2017 Jul; 46(7):267-273. PubMed ID: 28821890 [TBL] [Abstract][Full Text] [Related]
19. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia. Canfell K; Saville M; Caruana M; Gebski V; Darlington-Brown J; Brotherton J; Heley S; Castle PE BMJ Open; 2018 Jan; 8(1):e016700. PubMed ID: 29374658 [TBL] [Abstract][Full Text] [Related]
20. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women. Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]